The ATPase Thyroid hormone receptor interactor 13 (TRIP13), usually overexpressed in a myriad of human cancers, promotes glioblastoma migration and invasion by decreasing the transcription of FBXW7 and attenuating its inhibitory effects on c-MYC (109). Here, TRIP13 is linked to cancer.